![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
API Suppliers
US DMFs Filed
CEP/COS Certifications
JDMFs Filed
EU WC
Listed Suppliers
0
USA (Orange Book)
Europe
Canada
Australia
South Africa
Uploaded Dossiers
U.S. Medicaid
Annual Reports
https://www.indianpharmapost.com/drug-approval/glenmark-receives-anda-approval-for-brimonidine-tartrate-and-timolol-maleate-ophthalmic-solution-15658
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214987
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-may-15-2024-59166.pdf
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-june-7-2023-80553.pdf
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217195
https://www.prnewswire.com/news-releases/thea-pharma-inc-statement-related-to-akorns-voluntary-nationwide-recall-of-various-human-and-animal-drug-branded-ophthalmic-products-within-expiry-due-to-company-shutdown-301811331.html
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-january-25-2023-68767.pdf
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-january-4-2023-52000.pdf
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215598
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=091086
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=201949
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215520
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216533
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216596
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=091442
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=091087
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215936
https://www.businesswire.com/news/home/20210610005304/en/Glaukos-Achieves-Pipeline-Milestone-with-Completion-of-Patient-Enrollment-in-U.S.-NDA-Phase-3-Clinical-Trials-for-iDose%C2%AE-TR
https://news.google.com/topics/CAAqIQgKIhtDQkFTRGdvSUwyMHZNRE15YlhnU0FtVnVLQUFQAQ?hl=en-IN&gl=IN&ceid=IN:en
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212942
https://www.prnewswire.com/news-releases/new-products-launched-by-micro-labs-usa-inc-301138133.html
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212291
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-july-1-2020-1593586904.pdf
http://www.pharmatimes.com/news/santen_emea_announces_rwd_on_taptiqom_1327013
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-august-7-2019-1565155577.pdf
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207523
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207556
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-april-3-2019-1554267295.pdf
https://www.pharmacompass.com/pdf/news/Imprimis-Pharmaceuticals-Receives-FDA-Warning-Letter-1516167417.pdf
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-september-13-2017-1505277974.pdf
https://www.pharmacompass.com/pdf/news/forbidden-xalacom-eye-drops-of-pfizer-1477044514.pdf
http://www.biospectrumasia.com/biospectrum/news/222892/mundipharma-buys-mercks-ophthalmology-business
http://www.fiercebiotech.com/story/aeri-skyrockets-mixed-success-second-phiii-glaucoma-study/2015-09-16?utm_medium=rss&utm_source=rss&utm_campaign=rss